Anwendung komplementärer/alternativer Therapiemassnahmen bei Patientinnen mit Brustkrebs
Anwendung komplementärer/alternativer Therapiemassnahmen bei Patientinnen mit Brustkrebs
复制标题
与 Brustkrebs 一起的患者治疗的补充/替代疗法
DOI：
--
复制
发表时间：
2003
影响因子：
1.8
通讯作者：
K. Kisters
中科院分区：
文献类型：
--
作者：
K. Schönekaes;O. Micke;R. Mücke;J. Büntzel;M. Glatzel;F. Bruns;K. Kisters
乳腺癌患者使用补充/替代医学背景：补充/替代医学（CAM）越来越重要，特别是在乳腺癌患者的治疗中。本分析的目的是调查乳腺癌患者中CAM的患病率，以统计学方式描述所使用的制剂和治疗，并确定其使用原因、信息来源和个人感知。方法：对203例乳腺癌放疗患者的资料进行分析。中位年龄为54岁（范围38-77岁）。所有患者均接受手术作为首次治疗。36例患者因转移（27例患者）或局部复发（9例患者）接受二线放疗。结果：159例患者（78%）表示进行额外治疗。36例转移或局部复发患者中有31例使用CAM。维生素制剂（67%），槲寄生疗法（59%）和矿物质制剂（33%）使用最频繁。70%的患者使用两种或多种制剂/治疗的组合。使用CAM的最常见原因是提高生活质量（28%）和改善免疫系统（27%）。72%的人表示他们的个人感知有所改善。信息的主要来源是全科医生或妇科医生。结论：放射治疗师必须考虑这些补充/替代疗法;其重要性应在进一步的研究中进行评估。
Use of Complementary/Alternative Medicine by Patients with Breast Carcinoma Background: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. Patients and Methods: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38–77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). Results: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. Conclusion: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies.
影响因子：
158.5
作者：
Burstein, HJ;Gelber, S;Weeks, JC
通讯作者：
Weeks, JC
披露医疗遭遇中补充和替代医学的使用：一项针对乳腺癌女性的定性研究。
DOI：
--
发表时间：
1999
期刊：
The Journal of family practice
影响因子：
--
作者：
Adler,SR;Fosket,JR
通讯作者：
Fosket,JR
影响因子：
45.3
作者：
Richardson, MA;Sanders, T;Singletary, SE
通讯作者：
Singletary, SE